XXXX of the mandible and maxilla.

@entity1 @entity455 @entity1462 @entity600
OBJECTIVES/HYPOTHESIS: Vascular @entity600 involving the mandible and maxilla are uncommon, and no uniform treatment of these lesions has been defined. The purpose of the study was to evaluate the effectiveness of treating @entity1462 with a multidisciplinary approach and emphasis on endovascular therapy. STUDY DESIGN: Retrospective chart review of @entity1 . METHODS: The treatment of 31 @entity1 (13 male and 18 female @entity1 ) with mandibular and/or @entity1462 presenting between 1979 to 2001 was reviewed. RESULTS: Thirteen @entity1 (42%) presented with mandibular @entity1462 , and an equal number of @entity1 had @entity1462 . Five @entity1 had involvement of both the mandible and maxilla. Twenty-six @entity1 (84%) had adjacent soft tissue extension, whereas five @entity1 had a @entity1462 isolated either to the mandible (four cases) or maxilla (one case). Twenty-six cases consisted of @entity455 , and five @entity1 had venous and capillary types. Twenty-five @entity1 (81%) were treated with embolization only, whereas six @entity1 (19%) underwent combined embolization and surgical resection. "Cure" was defined as the complete eradication of disease or permanent resolution of symptoms with complete devascularization by embolization. The cure rates were 70% for mandibular @entity600 and 46% for maxillary lesions. None of the combined maxillary/mandibular lesions were cured, but all achieved improvement or stabilization of symptoms. The follow-up range was 1 to 22 years with an average follow-up of 6.7 years. CONCLUSION: The location and extent of @entity1462 dictate the treatment and resulting success. Endovascular therapy alone can effectively "cure" most mandibular and @entity1462 with limited soft tissue involvement. Extensive @entity1462 can be stabilized with control of symptoms, but eradication of the @entity1462 is unlikely even with combined surgery and embolization.
